A.   Nasal spray

B.   Liquid oral solutions

C.   Subcutaneous infusions

D.   Oral disintegrating tablets

A.   Nausea and Apical pulse of 56 beats per minute

B.   Urinary retention and Hypoactive bowel sounds

C.   Dry mouth and Hypoactive bowel sounds

D.   Urinary retention and Dry mouth

A.   Atropine available for immediate use. Electroencephalogram ready to place. Telemetry monitor on the patient. Blood pressure equipment for frequent monitoring.

B.   Atropine available for immediate use. Epinephrine available for immediate use. Electroencephalogram ready to place. Blood pressure equipment for frequent monitoring.

C.   Atropine available for immediate use. Epinephrine available for immediate use. Telemetry monitor on the patient.Blood pressure equipment for frequent monitoring.

D.   Atropine available for immediate use. Epinephrine available for immediate use. Telemetry monitor on the patient. Electroencephalogram ready to place.

A.   “I will take the medication 30 minutes before meals.”

B.   “I hope to feel improvement in muscle strength.”

C.   “I will review any over-the-counter medications with my health care provider.”

D.   “The medical alert in my health care record should cover me.”

A.   Increased responsibility for self-care

B.   Limit sleep during the day

C.   A walking program at least once a week

D.   Add more stimuli to the environment

A.   Increased arm strength

B.   Ability to speak clearly

C.   Ability to swallow without difficulty

D.   Decreased respiration

A.   Postoperative hypotension

B.   Urinary atony

C.   Respiratory atelectasis

D.   Postoperative ischemic colitis

A.   Memantine

B.   Atropine

C.   Donepezil

D.   Rivastigmine

A.   Macular degeneration

B.   Glaucoma

C.   Dry eye syndrome

D.   Cataracts

A.   Memantine

B.   Carbachol

C.   Physostigmine

D.   Tacrine

A.   Donepezil

B.   Pyridostigmine

C.   Atropine

D.   Echothiophate

A.   Pilocarpine

B.   Neostigmine

C.   Rivastigmine

D.   Succinylcholine

A.   Epinephrine

B.   Rivastigmine

C.   Memantine

D.   Atropine

A.   Cevimeline

B.   Donepezil

C.   Bethanechol

D.   Succinylcholine

A.   Administer epinephrine.

B.   Measure the patient’s urinary output.

C.   Monitor the patient’s heart rate.

D.   Assess the patient’s breath sounds.

A.   Ocular

B.   Intramuscular

C.   Oral

D.   Intravenous

A.   Pyridostigmine

B.   Donepezil

C.   Bethanechol

D.   Memantine

A.   Urinary retention

B.   Chronic refractory heartburn

C.   Hyperthyroidism

D.   Gastric atony

A.   Relaxed muscles

B.   Wakefulness

C.   Increased cognition

D.   Urination

A.   Neostigmine and Galantamine

B.   Neostigmine and Edrophonium

C.   Pilocarpine and Succinylcholine

D.   Galantamine and Edrophonium

A.   Gastrointestinal

B.   Neurologic

C.   Urinary

D.   Musculoskeletal

A.   A high dose of donepezil orally

B.   Physostigmine intravenously

C.   An antihistamine intravenously

D.   Dextrose solution intravenously

A.   Dry cough, Dizziness, Bradycardia, Hypotension

B.   Sweating, Dizziness, Dry cough, Hypotension

C.   Sweating, Dizziness, Bradycardia, Dry cough

D.   Sweating, Dizziness, Bradycardia, Hypotension

A.   Blood pressure 70/40 mm Hg

B.   Raised, erythematous rash

C.   Respiratory rate 30 breaths/min

D.   Inability to sleep

A.   Donepezil, Memantine, Pyridostigmine

B.   Neostigmine, Pyridostigmine, Physostigmine

C.   Donepezil, Neostigmine, Memantine

D.   Physostigmine, Donepezil, Memantine

A.   "You will take this medication once per week."

B.   "Do not take this medication with food."

C.   "Be cautious with activity until you know how the medication affects you."

D.   "Do not drink grapefruit juice while on this medication."

A.   "My family says that my memory has improved."

B.   "I have noticed that I have been urinating more frequently."

C.   "I feel like I am coughing up more phlegm."

D.   "I can tell my muscle strength has gotten better."

A.   Blood pressure 150/95 mm Hg

B.   Respiratory rate 24 breaths/min

C.   Constipation

D.   Heart rate 30 beats/min

A.   Memantine

B.   Edrophonium

C.   Bethanechol

D.   Physostigmine

A.   Call for someone before rising.

B.   Increase fluid intake to increase blood volume.

C.   Move from a sitting to standing position slowly.

D.   Take ibuprofen before rising.

A.   Donepezil

B.   Rivastigmine

C.   Memantine

D.   Galantamine

A.   Body mass index

B.   Bowel sounds

C.   Vital signs

D.   Blood glucose level

A.   "Let me assess what other medications the patient is taking."

B.   "I will call the health care provider and ask for the medication to be changed."

C.   "The medication has an onset of action of about 3 weeks."

D.   "Sometimes family members aren’t the best at assessing these things."

A.   Gastrointestinal (GI) upset, Ataxia, Dyspnea

B.   Ataxia, Dyspnea, Hypotension

C.   Insomnia, Hypotension, Gastrointestinal (GI) upset

D.   Ataxia, Insomnia, Dyspnea

A.   Hypothyroidism, Psoriatic arthritis.

B.   Emphysema, Psoriatic arthritis.

C.   Asthma, Coronary artery disease

D.   Emphysema, Hypothyroidism

A.   "Take the medication 30 minutes after eating."

B.   "Notify your health care provider if you have a headache."

C.   "Do not eat solid food."

D.   "Seek medical help if you develop nausea and vomiting."

A.   Nicotinic-receptor stimulation causes increased blood pressure. Muscarinic-receptor stimulation causes increased gastrointestinal motility. Nicotinic-receptor stimulation causes increased contraction of skeletal muscle.

B.   Nicotinic-receptor stimulation causes dilation of the pupils. Muscarinic-receptor stimulation causes constriction of blood vessels. Muscarinic-receptor stimulation causes increased gastrointestinal motility.

C.   Nicotinic-receptor stimulation causes dilation of the pupils. Muscarinic-receptor stimulation causes constriction of blood vessels. Nicotinic-receptor stimulation causes increased blood pressure.

D.   Nicotinic-receptor stimulation causes increased contraction of skeletal muscle. Nicotinic-receptor stimulation causes dilation of the pupils. Muscarinic-receptor stimulation causes constriction of blood vessels.

A.   Temporary improvement in cognitive skills

B.   Cognitive stabilization for a few months

C.   Gradual decrease in cognitive function

D.   Rapid cognitive changes with decline

A.   10 mg

B.   2 mg

C.   5 mg

D.   7 mg

A.   Hypoglycemia, Hypothyroidism, Dyspnea

B.   Dyspnea, Bronchoconstriction, Orthostatic hypotension

C.   Bronchoconstriction, Hypoglycemia, Hypothyroidism

D.   Orthostatic hypotension, Hypoglycemia, Hypothyroidism

A.   Inject bethanechol. Provide a high-fiber diet. Administer a stool softener. Ambulate the patient as tolerated. Increase fluid intake as tolerated.

B.   Administer atropine. Provide a high-fiber diet. Administer a stool softener. Ambulate the patient as tolerated. Increase fluid intake as tolerated.

C.   Inject bethanechol. Provide a high-fiber diet. Administer a stool softener. Administer atropine. Increase fluid intake as tolerated.

D.   Inject bethanechol. Administer atropine. Administer a stool softener. Ambulate the patient as tolerated. Increase fluid intake as tolerated.

A.   18 mg

B.   7 mg

C.   12 mg

D.   10 mg

A.   "Tell your health care provider if you have gastric pain that does not subside." "Do not take the medication if you feel tired." "Take the medication on an empty stomach."

B.   "Do not take the medication if you feel tired." "Take the medication on an empty stomach." "Get up slowly from a sitting or lying position."

C.   "Do not take the medication if you feel tired." "Take the medication on an empty stomach." "Your drug dose will be gradually increased."

D.   "Your drug dose will be gradually increased." "Get up slowly from a sitting or lying position." "Tell your health care provider if you have gastric pain that does not subside."

A.   An antidote to tricyclic antidepressant toxicity. Relieve severe constriction of the bronchioles. Treat a patient with a prolonged history of sleep deprivation

B.   Relieve severe constriction of the bronchioles. Diagnose and treat myasthenia gravis. Treat a patient with a prolonged history of sleep deprivation

C.   Diagnose and treat myasthenia gravis. An antidote in biochemical warfare. An antidote to tricyclic antidepressant toxicity

D.   Relieve severe constriction of the bronchioles. Treat a patient with a prolonged history of sleep deprivation. An antidote in biochemical warfare

A.   Peptic ulcer and nonobstructive urinary retention

B.   Post orthopedic surgery, low urinary output and bronchial wheezing

C.   Decreased urination with possible renal calculi

D.   Urinary retention from neurogenic atony of the bladder

A.   Get up slowly. Eat something if you feel nauseated. You may have some trouble sleeping. Tell your health care provider if you have stomach pains.

B.   Get up slowly. Eat something if you feel nauseated. Stop the medication if you have headaches. Tell your health care provider if you have stomach pains.

C.   Get up slowly. Eat something if you feel nauseated. You may have some trouble sleeping. Stop the medication if you have headaches.

D.   Stop the medication if you have headaches. Eat something if you feel nauseated. You may have some trouble sleeping. Tell your health care provider if you have stomach pains.

A.   Ataxia and Bleeding

B.   Ataxia and Cramps

C.   Diarrhea and Syncope

D.   Bleeding and Cramps

A.   Cardiovascular status, Pain assessment, Complete blood count, Neurologic status

B.   Neurologic status, Cardiovascular status, Gastrourinary (GU) status, Assess for suicidal tendencies

C.   Pain assessment, Complete blood count, Gastrourinary (GU) status, Assess for suicidal tendencies

D.   Cardiovascular status, Gastrourinary (GU) status, Pain assessment, Complete blood count

A.   A walking program at least once a week

B.   Add more stimuli to the environment

C.   Increased responsibility for self-care

D.   Limit sleep during the day

A.   “The medical alert in my health care record should cover me.”

B.   “I will take the medication 30 minutes before meals.”

C.   “I will review any over-the-counter medications with my health care provider.”

D.   “I hope to feel improvement in muscle strength.”

A.   Pupil dilation and Decreased sweat gland secretion

B.   Decreased gastric motility and Decreased sweat gland secretion

C.   Decreased heart rate and Increased respiratory secretions

D.   Decreased gastric motility and Pupil dilation

A.   Assessment of bowel sounds

B.   Administration of another dose in an hour

C.   Assessment of blood pressure

D.   Administration of a second drug

A.   Hair loss and Constipation

B.   Constipation and Mydriasis

C.   Hair loss and Mydriasis

D.   Hypertension and Syncope

A.   Able to walk long distances

B.   Increased muscle strength

C.   Improved memory

D.   No longer dizzy

A.   Improved vision

B.   Increased muscle strength

C.   Relief of dry skin

D.   Moist oral mucous membranesn

A.   Decreased heart rate

B.   Pupil dilation

C.   Pupil constriction

D.   Elevated heart rate

A.   Lidocaine

B.   Epinephrine

C.   Atropine

D.   Dopamine

A.   "This medication should cure your Alzheimer’s disease."

B.   "This medication will increase your ability to sleep without dreaming."

C.   "This medication will enhance your memory."

D.   "You will only need to take this medication for 3 months."

A.   Peptic ulcer, Parkinsonism, Hyperthyroidism, Coronary artery disease

B.   Emphysema, Type 2 diabetes mellitus, Peptic ulcer, Parkinsonism,

C.   Hyperthyroidism, Coronary artery disease, Emphysema, Type 2 diabetes mellitus

D.   Emphysema, Type 2 diabetes mellitus, Parkinsonism, Hyperthyroidism,

A.   Administer after dissolving in water.

B.   Administer with fruit juices.

C.   Administer after meals.

D.   Administer 30 minutes before meals.